22:48 , Mar 9, 2017 |  BC Innovations  |  Finance

Pharmas learn their A, B, seeds

Having stepped in to fill the venture funding void after the financial crisis, corporate VCs are emerging as financing engines for new company formation. Driven largely by the flood of interest in immuno-oncology, pharmas are...
07:00 , Apr 4, 2016 |  BC Week In Review  |  Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc., Watertown, Mass.   Business: Cancer, Infectious, Antibodies   Date completed: 2016-03-30   Type: Venture financing   Raised: $8.6 million   Investors: Cormorant Asset Management; Sanofi-Genzyme BioVentures; Partners Innovation Fund   Note: The financing is a series A-1 round.   ...
08:00 , Jan 13, 2014 |  BC Week In Review  |  Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc., Watertown, Mass.   Business: Cancer, Infectious, Antibodies   Date completed: 1/6/14   Type: Venture financing   Raised: $3.6 million   Investors: Private investors   ...
08:00 , Jan 16, 2012 |  BC Week In Review  |  Financial News

ImmuneXcite completes venture financing

ImmuneXcite Inc., Watertown, Mass.   Business: Cancer, Infectious, Antibodies   Date completed: 1/3/12   Type: Venture financing   Raised: $2.4 million   Note: The company raised $2.4 million in a financing, according to an SEC filing.   ...
00:53 , Jan 14, 2012 |  BC Extra  |  Financial News

ImmuneXcite raises $2.4 million

ImmuneXcite Inc. (Watertown, Mass.) raised $2.4 million in a financing, according to an SEC filing. The company, which declined to comment, is developing technology to enhance the efficacy of mAbs for cancer and infectious disease...